Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 298

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Human Growth Hormone

Thomas, Michael J., Thomas, John A.·1988·Drugs, Athletes, and Physical Performance

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/978-1-4684-5499-4_13

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Research works printed but not linked: 23

  1. Raiti S, Tolman RA (eds): Human Growth Hormone. New York, Plenum Medical Book Co., 1986.
  2. Li CH, Chung C, Hans-Werner L, Stein S: The primary structure of monkey pituitary growth hormone. Arch Biochem Biophys 245: 287–291, 1986. · doi:10.1016/0003-9861(86)90216-x
  3. Li CH, Bewley TA, Chung D, Oosthuizen MMJ: Elephant growth hormone. Int J Peptide Prot Res 29: 62–67, 1987. · doi:10.1111/j.1399-3011.1987.tb02230.x
  4. Hughes JP, Friesen HG: The nature and regulation of the receptors for pituitary growth hormone. Annu Rev Physiol 47: 469–482, 1985. · doi:10.1146/annurev.ph.47.030185.002345
  5. Murad F, Haynes RC Jr: Adenohypophyseal hormones and related substances, in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics, ed 7. New York, Macmillan Publishing Co., 1985, pp 1362–1388.
  6. Underwood LE, Van Wyk JJ: Normal and aberrant growth, in Wilson JD, Foster DW (eds): Williams Textbook of Endocrinology, ed 7. Philadelphia, W.B. Saunders Co., 1985, pp 155–205.
  7. Weyer B, Sonne O: Receptor-mediated degradation of human growth hormone in rat adipocytes and cultured human lymphocytes (IM-9). Mol Cell Endocrinol 41: 85–92, 1985. · doi:10.1016/0303-7207(85)90145-5
  8. Gertler A, Friesen HG: Human growth hormone-stimulated mitogenesis of Nb2 node lymphoma cells is not mediated by an immediate acceleration of phosphoinositide metabolism. Mol Cell Endocrinol 48: 221–228, 1986. · doi:10.1016/0303-7207(86)90045-6
  9. Mittra I: Somatomedins and proteolytic bioactiviation of prolactin and growth hormone. Cell 38: 347348, 1984. · doi:10.1016/0092-8674(84)90488-4
  10. Grant MB, Schmetz I, Russell B, et al: Changes in insulin-like growth factors I and II and their binding protein after a single intramuscular injection of growth hormone. J Clin Endocrinol Metab 63(4):981–984, 1986. · doi:10.1210/jcem-63-4-981
  11. Skottner A, Fryklund L, Hansson HA: Experimental research on IGF-1. Acta Paediatr Scand 325 (suppl): 107–114, 1986. · doi:10.1111/j.1651-2227.1986.tb10376.x
  12. Scheithauer BW, Kovacs K, Randall RV, et al: Pathology of excessive production of growth hormone. Clin Endocrinol Metab 15 (3): 655–681, 1986. · doi:10.1016/s0300-595x(86)80014-7
  13. Wass JAH, Laws ER Jr, Randall RV, Sheline GE: The treatment of acromegaly. Clin Endocrinol Metab 15 (3): 683–707, 1986. · doi:10.1016/s0300-595x(86)80015-9
  14. Oppizzi G, Petroncini MM, Dallabonzana D, et al: Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation. J ClinEndocrinol Metab 63(6):13481353, 1986. · doi:10.1210/jcem-63-6-1348
  15. Albertsson-Wikland K: Growth hormone treatment in short children. Acta Paediatr Scand 325 (suppl): 6470, 1986.
  16. Takano K, Hizuka N, Shizume K: Treatment of Turner’s syndrome with methionyl human growth hormone for six months. Acta Endocrinol 112: 130–137, 1986. · doi:10.1530/acta.0.1120130
  17. Girard F, Gourmelen M: Clinical experience with somatonorm. Acta Paediatr Scand 325 (suppl): 29–32, 1986. · doi:10.1111/j.1651-2227.1986.tb10360.x
  18. Milner RDG: Clinical experience with somatren: UK preliminary report. Acta Paediatr Scand 325 (suppl): 25–28, 1986. · doi:10.1111/j.1651-2227.1986.tb10359.x
  19. Westphal O: Experiences of somatonorm in Sweden. Acta Paediatr Scand 325 (suppl): 41–44, 1986. · doi:10.1111/j.1651-2227.1986.tb10362.x
  20. Underwood LE: Report on the conference on uses and possible abuses of biosynthetic human growth hormone. N Engl J Med 311: 606–608, 1984. · doi:10.1056/nejm198408303110925
  21. Andersson R: Immunological aspects of growth hormone. Acta Paediatr Scand 325 (suppl): 48–54, 1986. · doi:10.1111/j.1651-2227.1986.tb10364.x
  22. Kaplan SL: Current status of the treatment of growth hormone deficiencies. 68th Annual Meeting Endocrine Society Proceedings, June, 1986.
  23. Fryklund LM, Bierich JR, Ranke MB: Recombinant human growth hormone. Clin Endocrinol Metab 15 (3): 511–535, 1986 · doi:10.1016/s0300-595x(86)80009-3

Cited by

See all 298

Metadata

Authors
Thomas, M. J., & Thomas, J. A.
Venue
Drugs, Athletes, and Physical Performance
Publisher
Springer US
Published
1988
Volume
46
Issue
1
Pages
199-216
OpenAlex
W1771833573
Cited by
298
References
27
FWCI
30.53
Type
book chapter
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human Growth Hormone. https://app.cochat.ai/papers/10.1007/978-1-4684-5499-4_13
The paper
Thomas, M. J., & Thomas, J. A. (1988). Human Growth Hormone. Drugs, Athletes, and Physical Performance. https://doi.org/10.1007/978-1-4684-5499-4_13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.